| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701929 | Journal of Thoracic Oncology | 2017 | 26 Pages |
Abstract
Our results suggest that trametinib and 4-MU are promising therapeutic agents in MPM and that further study of the combination is warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hiroyuki MD, Seiji MD, PhD, Yoshiko MS, Ayumi MD, Toshi MD, PhD, Makoto MD, PhD, Nobuyuki MD, PhD, Ikuko MD, PhD, Takashi MD, PhD, Primo N. MD, David R. MD, Hiroshi MD, PhD, Seiki MD, PhD,